News
German Cancer Congress 2022
Improving the interfaces between innovation and care "Cancer medicine: interfaces between...
Joint press release by the NCT/UCC Dresden and the NCT Heidelberg
Patient perspectives closely interlinked: focus areas of the Patient Advisory Board NCT Heidelberg
The Patient Advisory Board is firmly anchored at the NCT Heidelberg. This is also reflected by the...
ESMO Examination on Sept. 10, 2022
Saturday, Sept. 10, 2022, the ESMO exam for medical oncologists will be held in the lecture hall of...
Does COVID-19 vaccination increase the risk of cancer patients undergoing therapy with immune...
Exchange and training for future leaders - that was the goal of the third TRYTRAC meeting, for which...
Therapy for rare cancers: NCT scientists from Heidelberg and Dresden receive the Paul Martini Prize
Joint press release by the NCT Heidelberg and the NCT/UCC Dresden
A transatlantic group of researchers at the National Center for Tumor Diseases (NCT) Heidelberg, the...
Information, support, exchange: Virtual encounters at the 17th Heidelberg CancerPatient Day
On Saturday, April 2, 2022, this year's Heidelberg CancerPatient Day was once again held as a...
New members in the Managing Directorate
The managing directorate of the National Center for Tumor Diseases (NCT) Heidelberg is expanding and...